Table 2.
Main clinical manifestations of women and men with paracoccidioidomycosis.
| FEMALE | MALE | |||
|---|---|---|---|---|
| Clinical Manifestation | Acute/Subacute Form (n = 11) |
Chronic Form (n = 25) |
Acute/Subacute Form (n = 22) |
Chronic Form (n = 50) |
| Fever | 7 63.6% |
1 * 4% |
19 86.4% |
18 * 36% |
| Weight Loss | 10 * 90.9% |
13 52% |
10 * 45.5% |
37 74% |
| Jaundice | 5 45.5% |
0 0% |
4 18.2% |
1 2% |
| Lymph Node Involvement Number of affected chains/patients a |
11 100% 3.9 ± 1.6 |
5 20% 0.3 ± 0.7 |
20 90.9% 3.3 ± 1.9 |
19 38% 0.6 ± 1 |
| Hepatomegaly | 7 63.6% |
2 8% |
10 45.5% |
4 8% |
| Splenomegaly | 6 54.4% |
0 0% |
7 31.8% |
3 6% |
| Skin Lesion | 6 54.5% |
3 * 12% |
9 40.9% |
22 * 44% |
| Ulceration of the Oral/Nasal Mucosa | 1 9% |
10 40% |
5 22.7% |
26 52% |
| Larynx Involvement | 0 0% |
6 24% |
1 4.5% |
9 18% |
| Lung Injury | 3 27.3% |
20 80% |
4 18.2% |
41 82% |
| Bone Lesion | 0 0% |
2 8% |
0 0% |
2 4% |
| CNS Injury | 0 0% |
1 4% |
0 0% |
3 6% |
* p < 0.01. a Mean ± Std. Deviation; chains considered: cervical, supraclavicular, axillary, thoracic, abdominal, and inguinal.